PARLIAMENTARY WRITTEN QUESTION
Coronavirus: Vaccination (9 February 2021)
Question Asked
Asked by:
Lee Anderson (Reform UK)
Answer
Public Health England is leading on the surveillance of the COVID-19 vaccine programme and has developed a surveillance strategy to monitor the effectiveness of COVID-19 vaccines against mortality, hospitalisations, confirmed infections, markers of infectiousness and the impact on transmission.
Whilst phase three clinical trials provided evidence of vaccine effectiveness against symptomatic disease, further evidence is needed on how effectiveness varies by subgroup, including by age. This will be done using advanced surveillance techniques once the earliest eligible cohorts have been offered a full course of vaccination.
Answered by:
Nadhim Zahawi (Conservative)
19 February 2021
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.